Teradyne (TER) Cash & Equivalents (2009 - 2026)

Teradyne (TER) has reported Cash & Equivalents for 18 consecutive years, with $241.9 million the latest figure, recorded in Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $241.9 million, down 49.13% year-over-year; the trailing twelve-month figure through Mar 2026 was $241.9 million (down 49.13% YoY), and the FY2025 annual result was $293.8 million, down 46.91% from the prior year.
• Cash & Equivalents was $241.9 million for Q1 2026 at Teradyne, down from $293.8 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $854.8 million in Q4 2022 and troughed at $241.9 million in Q1 2026.
• Average Cash & Equivalents over 5 years is $553.2 million, with a median of $572.0 million recorded in 2022.
• Year-over-year, Cash & Equivalents increased 8.96% in 2024 and slumped 49.13% in 2026.
• Over 5 years, Cash & Equivalents stood at $854.8 million in 2022, then slipped by 11.37% to $757.6 million in 2023, then dropped by 26.96% to $553.4 million in 2024, then slumped by 46.91% to $293.8 million in 2025, then declined by 17.64% to $241.9 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $241.9 million in Q1 2026, $293.8 million in Q4 2025, and $272.7 million in Q3 2025.